Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice

Human papillomavirus vaccine (HPVv) is used worldwide for prevention of infection. However several reports link this vaccine, with immune-mediated reactions, especially with neurological manifestations. Our previous results showed that HPVv-Gardasil and aluminum-immunized mice developed behavioral i...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24282
Acceso en línea:
https://doi.org/10.1007/s12026-016-8818-6
https://repository.urosario.edu.co/handle/10336/24282
Palabra clave:
Aluminum hydroxide
Phospholipid
Wart virus vaccine
Aluminum hydroxide
Immunological adjuvant
Pharmaceutical vehicles and additives
Phospholipid
Wart virus vaccine
Animal experiment
Article
Body weight
Concentration (parameters)
Controlled study
Depression
Diet supplementation
Female
Forced swim test
Immunization
Motor performance
Mouse
Nonhuman
Phospholipid
Priority journal
Rotarod test
Single drug dose
Animal
Animal behavior
C57bl mouse
Depression
Dietary supplement
Drug effects
Motor activity
Swimming
Vaccination
Aluminum hydroxide
Animals
Depression
Dietary supplements
Female
Human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18
Mice
Motor activity
Phospholipids
Swimming
Vaccination
Aluminum
Autoimmunity
Behavior
Depression
Gardasil
immunologic
inbred c57bl
animal
pharmaceutic
Adjuvants
Adjuvants
Behavior
Mice
Rights
License
Abierto (Texto Completo)
id EDOCUR2_a4876078abc74556c999cf4f37572afa
oai_identifier_str oai:repository.urosario.edu.co:10336/24282
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling e0647900-20ef-41d2-a11d-fd3a007b02a0232ce352-6420-4ab4-ac33-901ea6e15362808734756008e6c26dd-7c93-449b-a6e6-fbae80578a2f6b286b69-16c0-4eae-a12c-57f7a4b4c7592020-05-26T00:11:07Z2020-05-26T00:11:07Z2017Human papillomavirus vaccine (HPVv) is used worldwide for prevention of infection. However several reports link this vaccine, with immune-mediated reactions, especially with neurological manifestations. Our previous results showed that HPVv-Gardasil and aluminum-immunized mice developed behavioral impairments. Studies have shown a positive effect of phospholipid supplementation on depression and cognitive functions in mice. Therefore, our goal was to evaluate the effect of a dietary supplement on vaccine-induced depression. Sixty C57BL/6 female mice were immunized with HPVv-Gardasil, aluminum or the vehicle (n = 20 each group), and half of each group were fed 5 times per week with 0.2 ml of a dietary supplement enriched with phosphatidylcholine. The mice were evaluated for depression at 3 months of age, by the forced swimming test. Both the Gardasil and the aluminum-treated mice developed depressive-like behavior when compared to the control group. The HPVv-Gardasil-immunized mice supplemented with phosphatidylcholine significantly reduced their depressive symptoms. This study confirms our previous studies demonstrating depressive-like behavior in mice vaccinated with HPVv-Gardasil. In addition, it demonstrates the ability of phosphatidylcholine-enriched diet to attenuate depressive-like behavior in the HPVv-Gardasil-vaccinated mice. We suggest that phosphatidylcholine supplementation may serve as a treatment for patients suffering vaccine-related neurological manifestations. © 2016, Springer Science+Business Media New York.application/pdfhttps://doi.org/10.1007/s12026-016-8818-60257277Xhttps://repository.urosario.edu.co/handle/10336/24282engHumana Press Inc.105No. 199Immunologic ResearchVol. 65Immunologic Research, ISSN:0257277X, Vol.65, No.1 (2017); pp. 99-105https://www.scopus.com/inward/record.uri?eid=2-s2.0-84980018603&doi=10.1007%2fs12026-016-8818-6&partnerID=40&md5=e12c6ba2e41eb0a2d99d8df9522ec66cAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAluminum hydroxidePhospholipidWart virus vaccineAluminum hydroxideImmunological adjuvantPharmaceutical vehicles and additivesPhospholipidWart virus vaccineAnimal experimentArticleBody weightConcentration (parameters)Controlled studyDepressionDiet supplementationFemaleForced swim testImmunizationMotor performanceMouseNonhumanPhospholipidPriority journalRotarod testSingle drug doseAnimalAnimal behaviorC57bl mouseDepressionDietary supplementDrug effectsMotor activitySwimmingVaccinationAluminum hydroxideAnimalsDepressionDietary supplementsFemaleHuman papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18MiceMotor activityPhospholipidsSwimmingVaccinationAluminumAutoimmunityBehaviorDepressionGardasilimmunologicinbred c57blanimalpharmaceuticAdjuvantsAdjuvantsBehaviorMicePhospholipid supplementation can attenuate vaccine-induced depressive-like behavior in micearticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Kivity S.Arango M.-T.Molano González, NicolásBlank M.Shoenfeld Y.10336/24282oai:repository.urosario.edu.co:10336/242822022-05-02 07:37:16.753858https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
title Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
spellingShingle Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
Aluminum hydroxide
Phospholipid
Wart virus vaccine
Aluminum hydroxide
Immunological adjuvant
Pharmaceutical vehicles and additives
Phospholipid
Wart virus vaccine
Animal experiment
Article
Body weight
Concentration (parameters)
Controlled study
Depression
Diet supplementation
Female
Forced swim test
Immunization
Motor performance
Mouse
Nonhuman
Phospholipid
Priority journal
Rotarod test
Single drug dose
Animal
Animal behavior
C57bl mouse
Depression
Dietary supplement
Drug effects
Motor activity
Swimming
Vaccination
Aluminum hydroxide
Animals
Depression
Dietary supplements
Female
Human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18
Mice
Motor activity
Phospholipids
Swimming
Vaccination
Aluminum
Autoimmunity
Behavior
Depression
Gardasil
immunologic
inbred c57bl
animal
pharmaceutic
Adjuvants
Adjuvants
Behavior
Mice
title_short Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
title_full Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
title_fullStr Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
title_full_unstemmed Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
title_sort Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice
dc.subject.keyword.spa.fl_str_mv Aluminum hydroxide
Phospholipid
Wart virus vaccine
Aluminum hydroxide
Immunological adjuvant
Pharmaceutical vehicles and additives
Phospholipid
Wart virus vaccine
Animal experiment
Article
Body weight
Concentration (parameters)
Controlled study
Depression
Diet supplementation
Female
Forced swim test
Immunization
Motor performance
Mouse
Nonhuman
Phospholipid
Priority journal
Rotarod test
Single drug dose
Animal
Animal behavior
C57bl mouse
Depression
Dietary supplement
Drug effects
Motor activity
Swimming
Vaccination
Aluminum hydroxide
Animals
Depression
Dietary supplements
Female
Human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18
Mice
Motor activity
Phospholipids
Swimming
Vaccination
Aluminum
Autoimmunity
Behavior
Depression
Gardasil
topic Aluminum hydroxide
Phospholipid
Wart virus vaccine
Aluminum hydroxide
Immunological adjuvant
Pharmaceutical vehicles and additives
Phospholipid
Wart virus vaccine
Animal experiment
Article
Body weight
Concentration (parameters)
Controlled study
Depression
Diet supplementation
Female
Forced swim test
Immunization
Motor performance
Mouse
Nonhuman
Phospholipid
Priority journal
Rotarod test
Single drug dose
Animal
Animal behavior
C57bl mouse
Depression
Dietary supplement
Drug effects
Motor activity
Swimming
Vaccination
Aluminum hydroxide
Animals
Depression
Dietary supplements
Female
Human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18
Mice
Motor activity
Phospholipids
Swimming
Vaccination
Aluminum
Autoimmunity
Behavior
Depression
Gardasil
immunologic
inbred c57bl
animal
pharmaceutic
Adjuvants
Adjuvants
Behavior
Mice
dc.subject.keyword.eng.fl_str_mv immunologic
inbred c57bl
animal
pharmaceutic
Adjuvants
Adjuvants
Behavior
Mice
description Human papillomavirus vaccine (HPVv) is used worldwide for prevention of infection. However several reports link this vaccine, with immune-mediated reactions, especially with neurological manifestations. Our previous results showed that HPVv-Gardasil and aluminum-immunized mice developed behavioral impairments. Studies have shown a positive effect of phospholipid supplementation on depression and cognitive functions in mice. Therefore, our goal was to evaluate the effect of a dietary supplement on vaccine-induced depression. Sixty C57BL/6 female mice were immunized with HPVv-Gardasil, aluminum or the vehicle (n = 20 each group), and half of each group were fed 5 times per week with 0.2 ml of a dietary supplement enriched with phosphatidylcholine. The mice were evaluated for depression at 3 months of age, by the forced swimming test. Both the Gardasil and the aluminum-treated mice developed depressive-like behavior when compared to the control group. The HPVv-Gardasil-immunized mice supplemented with phosphatidylcholine significantly reduced their depressive symptoms. This study confirms our previous studies demonstrating depressive-like behavior in mice vaccinated with HPVv-Gardasil. In addition, it demonstrates the ability of phosphatidylcholine-enriched diet to attenuate depressive-like behavior in the HPVv-Gardasil-vaccinated mice. We suggest that phosphatidylcholine supplementation may serve as a treatment for patients suffering vaccine-related neurological manifestations. © 2016, Springer Science+Business Media New York.
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:11:07Z
dc.date.available.none.fl_str_mv 2020-05-26T00:11:07Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1007/s12026-016-8818-6
dc.identifier.issn.none.fl_str_mv 0257277X
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/24282
url https://doi.org/10.1007/s12026-016-8818-6
https://repository.urosario.edu.co/handle/10336/24282
identifier_str_mv 0257277X
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 105
dc.relation.citationIssue.none.fl_str_mv No. 1
dc.relation.citationStartPage.none.fl_str_mv 99
dc.relation.citationTitle.none.fl_str_mv Immunologic Research
dc.relation.citationVolume.none.fl_str_mv Vol. 65
dc.relation.ispartof.spa.fl_str_mv Immunologic Research, ISSN:0257277X, Vol.65, No.1 (2017); pp. 99-105
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-84980018603&doi=10.1007%2fs12026-016-8818-6&partnerID=40&md5=e12c6ba2e41eb0a2d99d8df9522ec66c
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Humana Press Inc.
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808391114124689408